Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,39
KB0,06
PKN102,55102,650,24
Msft1,29
Nokia3,123,133,46
IBM0,30
Daimler AG50,6450,67-0,90
PFE2,00
16.11.2019 2:00:00
Indexy online
AD Index online
select
AD Index online
 

  • 15.11.2019 16:48:31
Danaher Corp (DHR.F, Frankfurt)
Závěr k 15.11.2019 Změna (%) Změna (EUR) Objem obchodů (EUR)
128,40 4,02 4,96 29 746
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 17.11.2019
Popis společnosti
Obecné informace
Název společnostiDanaher Corporation
TickerDHR
Kmenové akcie:Ordinary Shares
RICDHR
ISINUS2358511028
Poslední známé roční výsledky31.12.2018
Poslední známé čtvrtletní výsledky27.09.2019
Počet zaměstnanců k 31.12.2018 71 000
Akcie v oběhu k 18.10.2019 718 281 174
Počet akcionářů k 31.12.2018 2 500
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice2200 Pennsylvania Ave NW Ste 800w
MěstoWASHINGTON
PSČ20037-1731
ZeměUnited States
Kontatní osobaMatthew Gugino
Funkce kontaktní osobyVice President - Investor Relations
Telefon12 028 280 850
Fax12028280860

Business Summary: Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.
Financial Summary: BRIEF: For the nine months ended 27 September 2019, Danaher Corporation revenues increased 4% to $15.07B. Net income applicable to common stockholders decreased 12% to $1.68B. Revenues reflect Life sciences segment increase of 8% to $5.04B, DIAGNOSTICS segment increase of 4% to $4.76B, Environmental & Applied Solutions segment increase of 2% to $3.25B. Net income was offset by Other segment loss increase of 82% to $302.8M.
Odvětvová klasifikace
TRBC2009Industrial Machinery / Equipment
TRBC2012Advanced Medical Equipment & Technology - NEC
RBSS2004Industrial Machinery & Equipment
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSInstruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
NAICSOther Commercial and Service Industry Machinery Manufacturing
NAICSPetroleum and Petroleum Products (except Bulk Stations and Terminals) Wholesalers
NAICSTesting Laboratories
NAICSInstrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSDental Equipment and Supplies Manufacturing
NAICSAll Other Business Support Services
NAICSHand and Edge Tool Manufacturing
NAICSOffices of Other Holding Companies
SICProcess Control Instruments
SICProcess Control Instruments
SICService Industry MacHinery, Nec
SICPetroleum Products, Nec
SICTesting Laboratories
SICInstruments To Measure Electric
SICElectromedical Equipment
SICDental Equipment And Supplies
SICBusiness Services, Nec
SICHand And Edge Tools, Nec
SICHolding Companies, Nec



  • Poslední aktualizace: 17.11.2019
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardSteven Rales68
Chief Financial Officer, Executive Vice PresidentMatthew McGrew4701.01.201901.01.2019
Executive Vice PresidentRainer Blair54
Executive Vice PresidentDaniel Comas5531.12.201801.01.1996
Executive Vice PresidentWilliam Daniel5425.07.2008
Executive Vice PresidentJoakim Weidemanis4928.11.201728.11.2017
Senior Vice President, Chief Accounting OfficerRobert Lutz61
Senior Vice President, Chief Compliance Officer, General CounselBrian Ellis52
Senior Vice President - Human ResourcesAngela Lalor5304.04.201204.04.2012
Senior Vice President - Strategic DevelopmentWilliam King51